GlassScriptPhysician profile
Suparna Shah
NPI 1023498276
$7,903.70
in general payments reported to CMS, 2019-2025
25 companies · $1,867 in 2025
The $1,867 reported for 2025 was more than what 89% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,377 · 2020: $190 · 2021: $88.38 · 2023: $2,666 · 2024: $715 · 2025: $1,867.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,407 · Travel and Lodging: $660 · Education: $160 · Gift: $21.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,406.79 |
| Travel and Lodging | $660.34 |
| Education | $160.22 |
| Gift | $21.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,205.65 | 2023-2025 | Inspire |
| Zimmer Biomet Holdings, INC. | $1,056.53 | 2019-2020 | |
| Medical Device Business Services, INC. | $988.87 | 2019 | |
| Medtronic, INC. | $838.70 | 2023-2025 | Pteye Parathyroid Detection System, Fusion, Sinuva |
| Olympus America INC. | $577.44 | 2020-2024 | Rhino-Laryngo Videoscope, Medical Control Unit For Endosurgery Uces-4 |
| Regeneron Healthcare Solutions, INC. | $459.22 | 2023-2025 | Dupixent, Libtayo |
| Stryker Corporation | $371.24 | 2019-2024 | Na, Vsp System, Vsp Cranial, Scopis Ent |
| Axogen | $360.44 | 2019-2025 | |
| Hologic Sales and Service, LLC | $149.67 | 2025 | Coolseal Generator |
| Intersect Ent, INC. | $126.11 | 2019 | |
| Merck Sharp & Dohme LLC | $106.55 | 2025 | Keytruda |
| Atos Medical INC | $94.35 | 2024 | Provox Life Home Hme |
| Genzyme Corporation | $91.82 | 2025 | |
| Depuy Synthes Sales INC. | $88.38 | 2021 | |
| Kls-Martin L.P. | $72.91 | 2023 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $56.99 | 2025 | |
| Karl Storz Endoscopy-America | $48.78 | 2023 | N.A. |
| Precigen, INC. | $47.22 | 2025 | |
| Acclarent, INC | $44.34 | 2019 | |
| Medtronic USA, INC. | $28.37 | 2019-2020 | |
| Smith+Nephew, INC. | $21.25 | 2025 | Stravix |
| Carl Zeiss Meditec USA, INC. | $21.00 | 2025 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Optinose US, INC. | $16.17 | 2023 | |
| Glaxosmithkline, LLC. | $14.46 | 2023 | Nucala |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suparna Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.